7-hydroxymitragynine, commonly known as 7-OH, is a kratom-associated alkaloid that appears in several modern product formats, including tablets, extracts, liquids, and vaping formulations. Although these products may contain the same primary compound, their formulations and delivery methods can differ significantly.

Understanding these differences is important when comparing products or interpreting research.

7-OH Vapes

A 7-OH vape is designed to deliver a formulation through inhalation. Unlike an oral tablet or powder, the product is heated to produce an aerosol that enters the respiratory system.

This creates additional research questions because the chemical composition of the original liquid may not be identical to the compounds present after heating. Temperature, device characteristics, formulation ingredients, and aerosol properties can all influence the final exposure.

Research into nonswallowed kratom-derived products has identified vaping as a prominent product category, while also highlighting limited clinical and pharmacokinetic data.

7-OH Tablets

Tablets provide 7-OH in a solid formulation intended for oral administration. Their chemical composition can include the stated alkaloid along with binders, flavoring agents, or other ingredients.

One important consideration is label accuracy. Recent laboratory research has identified discrepancies between labeled and measured 7-OH concentrations in some commercial products.

Unlike vaping products, tablets do not introduce the same heating-related questions, but oral products are still affected by factors such as absorption, metabolism, formulation, and individual differences.

Kratom Extracts and Powders

Traditional kratom powder is produced from Mitragyna speciosa leaves and contains a naturally occurring mixture of alkaloids.

Mitragynine is generally the predominant alkaloid, while 7-OH normally occurs at much lower levels in natural leaf material.

Extracts can concentrate certain components of the plant and therefore may have a chemical profile different from untreated leaf powder. The term "extract" alone does not indicate a standardized concentration or composition.

Liquid Alkaloid Products

Liquid formulations represent another category. These may contain concentrated kratom alkaloids, extracts, or combinations of different compounds.

The liquid format can make formulation variables particularly important. Researchers may need to examine concentration, solvents or carrier materials, stability over time, and whether the contents remain consistent throughout the product's shelf life.

Why the Delivery Route Matters

The biggest distinction between these formats is often the route of administration.

Oral products pass through the gastrointestinal system before entering circulation and undergo processes associated with digestion and metabolism. Inhaled products expose the respiratory system directly to an aerosol and can follow a different absorption pathway.

Because of these differences, research involving oral 7-OH should not automatically be applied to inhaled 7-OH products.

Chemical Composition Is Equally Important

Product format is only one part of the comparison.

Two products can use different delivery systems while containing similar compounds, or they can use the same format while having very different chemical profiles.

Independent laboratory testing can help identify:

• 7-OH concentration

• Mitragynine and other alkaloids

• Additional active compounds

• Carrier ingredients

• Potential contaminants

• Degradation products

• Differences between labeled and measured content

This information is especially useful when studying newer concentrated products.

Current Safety Questions

The FDA currently recommends that consumers avoid concentrated 7-OH products and states that these products have not been proven safe or effective for any use. The agency has reported adverse effects associated with 7-OH products, including addiction, withdrawal symptoms, anxiety, depression, gastrointestinal distress, insomnia, and seizures.

For vaping products, additional questions concern respiratory exposure and the compounds generated when formulations are heated.

Research into these areas is still developing, so conclusions should be based on evidence specific to the product and delivery method being studied.

Final Thoughts

7-OH vapes differ from tablets, powders, extracts, and liquid products in both formulation and route of administration. Vaping introduces additional variables involving aerosol formation, heating, respiratory exposure, and potential chemical transformation.

Traditional kratom products, meanwhile, generally contain a broader mixture of naturally occurring alkaloids, while concentrated 7-OH products are formulated around enhanced levels of a particular compound.

For researchers and readers comparing these categories, the most useful approach is to examine chemical composition, concentration, formulation, delivery route, laboratory testing, and available scientific evidence together rather than assuming that all kratom-related products have the same properties.